Surrozen, Inc. (SRZN)
18.81
-1.87
(-9.04%)
USD |
NASDAQ |
Sep 09, 13:07
Surrozen Market Cap : 221.09M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 243.07M |
| September 04, 2026 | 267.52M |
| September 03, 2026 | 264.94M |
| September 02, 2026 | 265.64M |
| September 01, 2026 | 260.94M |
| August 31, 2026 | 258.82M |
| August 28, 2026 | 263.52M |
| August 27, 2026 | 282.21M |
| August 26, 2026 | 278.69M |
| August 25, 2026 | 274.57M |
| August 24, 2026 | 281.74M |
| August 21, 2026 | 281.98M |
| August 20, 2026 | 276.22M |
| August 19, 2026 | 282.21M |
| August 18, 2026 | 282.10M |
| August 17, 2026 | 279.51M |
| August 14, 2026 | 281.63M |
| August 13, 2026 | 278.92M |
| August 12, 2026 | 284.33M |
| August 11, 2026 | 294.44M |
| August 10, 2026 | 294.91M |
| August 07, 2026 | 301.14M |
| August 06, 2026 | 254.36M |
| August 05, 2026 | 258.00M |
| August 04, 2026 | 258.59M |
| Date | Value |
|---|---|
| August 03, 2026 | 250.25M |
| July 31, 2026 | 255.19M |
| July 30, 2026 | 239.34M |
| July 29, 2026 | 220.61M |
| July 28, 2026 | 222.91M |
| July 27, 2026 | 227.62M |
| July 24, 2026 | 226.70M |
| July 23, 2026 | 243.13M |
| July 22, 2026 | 249.56M |
| July 21, 2026 | 264.16M |
| July 20, 2026 | 254.62M |
| July 17, 2026 | 252.32M |
| July 16, 2026 | 238.42M |
| July 15, 2026 | 250.37M |
| July 14, 2026 | 251.40M |
| July 13, 2026 | 262.09M |
| July 10, 2026 | 266.45M |
| July 09, 2026 | 270.02M |
| July 08, 2026 | 262.89M |
| July 07, 2026 | 264.38M |
| July 06, 2026 | 271.85M |
| July 02, 2026 | 286.33M |
| July 01, 2026 | 293.22M |
| June 30, 2026 | 298.17M |
| June 29, 2026 | 295.52M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.91B |
| Oncolytics Biotech, Inc. | 100.68M |
| Sangamo Therapeutics, Inc. | 66.66M |
| Sarepta Therapeutics, Inc. | 2.355B |
| Anixa Biosciences, Inc. | 96.34M |
Market Cap Related Metrics
| PS Ratio | 21.15 |
| PEG Ratio | -0.0019 |
| Price | 18.81 |
| Earnings Yield | -235.4% |
| PEGY Ratio | -0.0019 |